Financials
- Market Capitalization 146.08 M
- Employee 61
- Founded 1996
- CEO N/A
- Website www.acumenpharm.com
- Headquarter Delaware, United States
- FIGI BBG0058YJ317
- Industry 生物工学
総売上高
当期純利益
1株当たり基本利益(基本EPS)
有利子負債合計
フリーキャッシュフロー
現金および現金同等物
株価収益率
-1.05
売上高対価格比率
638.93
Related tickers
| # | 名前 | 価格 | 24時間% | 7日% | 1か月% | 1年% | 時価総額 | 過去7日 | |
|---|---|---|---|---|---|---|---|---|---|
| 3674 | MOLN Molecular Partners AG - American Depositary Shares | 3.79 USD | -1.56% | -7.79% | -8.67% | +1.88% | 153.02 M USD | ||
| 3677 | NBP NovaBridge Biosciences - American Depositary Shares | 1.32 USD | -5.71% | -4.35% | -16.98% | -70.73% | 152.30 M USD | ||
| 3702 | OTLK Outlook Therapeutics, Inc. - Common Stock | 0.59 USD | -1.67% | -1.67% | -9.23% | +43.03% | 143.63 M USD | ||
| 3710 | RNA Atrium Therapeutics, Inc. - Common Stock | 8.21 USD | -2.26% | +2.63% | -20.83% | -88.33% | 140.44 M USD |